Molecular mapping of functional domains of the leukocyte receptor for endothelium, LAM-1

doi:10.1083/jcb.114.2.351

This Article

	Full Text (PDF, 1086K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kansas, G. S.
	Articles by Tedder, T. F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kansas, G. S.
	Articles by Tedder, T. F.


Social Bookmarking

	What's this?

ARTICLES

Molecular mapping of functional domains of the leukocyte receptor for endothelium, LAM-1

GS Kansas, O Spertini, LM Stoolman and TF Tedder
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115-6084.

The human lymphocyte homing receptor LAM-1, like its murine counterpart MEL-14, functions as a mammalian lectin, and mediates the binding of leukocytes to specialized high endothelial cells in lymphoid organs (HEV). LAM-1 is a member of a new family of cell adhesion molecules, termed selectins or LEC-CAMs, which also includes ELAM-1 and PAD-GEM (GMP-140/CD62). To localize the regions of LAM-1 that are involved in cell adhesion, we developed chimeric selectins, in which various domains of PAD-GEM were substituted into LAM-1, and used these chimeric proteins to define the domain requirements for carbohydrate binding, and to localize the regions recognized by several mAb which inhibit the adhesion of lymphocytes to lymph node HEV. The binding of PPME or fucoidin, soluble complex carbohydrates that specifically define the lectin activity of LAM-1 and MEL-14, required only the lectin domain of LAM-1. The LAM1-1, LAM1-3, and LAM1-6 mAb each strongly inhibit the binding of lymphocytes to HEV in the in vitro frozen section assay, and defined three independent epitopes on LAM-1. Blocking of PPME or fucoidin binding by LAM1-3 indicated that this site is identical, or in close proximity, to the carbohydrate binding site, and analysis of the binding of LAM1-3 to chimeric selectins showed that the epitope detected by LAM1-3 is located within the lectin domain. Although the LAM1-6 epitope is also located in the lectin domain, LAM1-6 did not affect the binding of PPME or fucoidin. The LAM1-1 epitope was located in, or required, the EGF domain, and, importantly, binding of LAM1-1 significantly enhanced the binding of both PPME and fucoidin. These results suggest that adhesion mediated by LAM-1 may involve cooperativity between functionally and spatially distinct sites, and support previous data suggesting a role for the EGF domain of LAM-1 in lymphocyte adhesion to HEV.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Waldron, T. T., Springer, T. A. (2009). Transmission of allostery through the lectin domain in selectin-mediated cell adhesion. Proc. Natl. Acad. Sci. USA 106: 85-90 [Abstract] [Full Text]
Springer, T. A. (2009). Structural basis for selectin mechanochemistry. Proc. Natl. Acad. Sci. USA 106: 91-96 [Abstract] [Full Text]
Hasegawa, M., Fujimoto, M., Poe, J. C., Steeber, D. A., Tedder, T. F. (2001). CD19 Can Regulate B Lymphocyte Signal Transduction Independent of Complement Activation. J. Immunol. 167: 3190-3200 [Abstract] [Full Text]
Kyriakides, C., Woodcock, S. A., Wang, Y., Favuzza, J., Austen, W. G. Jr., Kobzik, L., Moore, F. D. Jr., Valeri, R. C., Shepro, D., Hechtman, H. B. (2000). Soluble P-selectin moderates complement-dependent reperfusion injury of ischemic skeletal muscle. Am. J. Physiol. Cell Physiol. 279: C520-C528 [Abstract] [Full Text]
Kimura, N., Mitsuoka, C., Kanamori, A., Hiraiwa, N., Uchimura, K., Muramatsu, T., Tamatani, T., Kansas, G. S., Kannagi, R. (1999). Reconstitution of functional L-selectin ligands on a cultured human endothelial cell line by cotransfection of alpha 1right-arrow3 fucosyltransferase VII and newly cloned GlcNAcbeta :6-sulfotransferase cDNA. Proc. Natl. Acad. Sci. USA 96: 4530-4535 [Abstract] [Full Text]
Kurosawa, H., Goi, K., Inukai, T., Inaba, T., Chang, K.-S., Shinjyo, T., Rakestraw, K. M., Naeve, C. W., Look, A. T. (1999). Two Candidate Downstream Target Genes for E2A-HLF. Blood 93: 321-332 [Abstract] [Full Text]
Mehta, P., Patel, K. D., Laue, T. M., Erickson, H. P., McEver, R. P. (1997). Soluble Monomeric P-Selectin Containing Only the Lectin and Epidermal Growth Factor Domains Binds to P-Selectin Glycoprotein Ligand-1 on Leukocytes. Blood 90: 2381-2389 [Abstract] [Full Text]
Zollner, O., Lenter, M. C., Blanks, J. E., Borges, E., Steegmaier, M., Zerwes, H.-G., Vestweber, D. (1997). L-Selectin from Human, but Not from Mouse Neutrophils Binds Directly to E-Selectin. JCB 136: 707-716 [Abstract] [Full Text]
Brenner, B., Gulbins, E., Schlottmann, K., Koppenhoefer, U., Busch, G.�L., Walzog, B., Steinhausen, M., Coggeshall, K.�M., Linderkamp, O., Lang, F. (1996). L-Selectin activates the Ras pathway via the tyrosine kinase�p56lck. Proc. Natl. Acad. Sci. USA 93: 15376-15381 [Abstract] [Full Text]
Nelson, R.M., Aruffo, A., Dolich, S., Cecconi, O., Mannori, G., Bevilacqua, M.P. (1992). Quantitative Determination of Selectin-Carbohydrate Interactions. Cold Spring Harb Symp Quant Biol 57: 271-279 [Abstract]
Dwir, O., Kansas, Geoffrey. S., Alon, R. (2000). An Activated L-selectin Mutant with Conserved Equilibrium Binding Properties but Enhanced Ligand Recognition under Shear Flow. J. Biol. Chem. 275: 18682-18691 [Abstract] [Full Text]